![Arnd Kaltofen-Ehmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arnd Kaltofen-Ehmann
Directeur/Membre du Conseil chez
Araris Biotech AG
Profil
Arnd Kaltofen-Ehmann currently works at Inositec AG, as Director, Araris Biotech AG, as Director from 2020, and VI Partners AG, as Managing Partner from 2018.
Dr. Kaltofen-Ehmann also formerly worked at Oncalis AG, as Chairman from 2009 to 2011, JenaValve Technology GmbH, as Director, Spinelab AG, as Director, Vectura GmbH, as Director-Supervisory Board, Cardiola AG, as Director-Executive Board from 2009 to 2012, Cell Medica Switzerland AG, as Director, Kuros Biosciences Ltd., as Director, Thommen Medical AG, as Member-Management Board, ESBATech, a Novartis Co. GmbH, as Member-Management Board, and Ventaleon GmbH, as Member-Supervisory Board.
Dr. Kaltofen-Ehmann received his graduate degree from Technische Universität München, undergraduate degree from the University of Koblenz, and Masters Business Admin degree from Kellogg School of Management.
Postes actifs de Arnd Kaltofen-Ehmann
| Sociétés | Poste | Début |
|---|---|---|
VI Partners AG
 VI Partners AG Investment ManagersFinance VI Partners invests in companies located across the Europe, primarily in Switzerland. The firm targets companies operating in the fields of technology and healthcare. It participates in seed and early stage transactions and takes a seat on the board of directors. | Private Equity Investor | 01/08/2001 |
Inositec AG
 Inositec AG Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops treatments for progressive vascular calcification and soft tissue disorders | Directeur/Membre du Conseil | - |
Araris Biotech AG
 Araris Biotech AG BiotechnologyHealth Technology Operates as a biotechnology company that develops antibody-drug conjugates | Directeur/Membre du Conseil | 22/10/2020 |
Anciens postes connus de Arnd Kaltofen-Ehmann
| Sociétés | Poste | Fin |
|---|---|---|
Oncalis AG
 Oncalis AG Pharmaceuticals: MajorHealth Technology Develops oral therapies for oncology using kinase inhibitors | Président | 17/07/2009 |
| KUROS BIOSCIENCES AG | Directeur/Membre du Conseil | - |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Directeur/Membre du Conseil | - |
Vectura GmbH
 Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Directeur/Membre du Conseil | - |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products | Directeur/Membre du Conseil | - |
Formation de Arnd Kaltofen-Ehmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Oncalis AG
Oncalis AG Pharmaceuticals: MajorHealth Technology Develops oral therapies for oncology using kinase inhibitors | Health Technology |
Thommen Medical AG
 Thommen Medical AG Medical SpecialtiesHealth Technology Develops and manufactures dental implant systems | Health Technology |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VI Partners AG
VI Partners AG Investment ManagersFinance VI Partners invests in companies located across the Europe, primarily in Switzerland. The firm targets companies operating in the fields of technology and healthcare. It participates in seed and early stage transactions and takes a seat on the board of directors. | Finance |
University of Koblenz
 University of Koblenz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology Provides transcatheter valve implantation systems | Health Technology |
Spinelab AG
 Spinelab AG Medical/Nursing ServicesHealth Services Specializes in the field of non-fusion spine technologies | Health Services |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
Cardiola AG
 Cardiola AG Medical SpecialtiesHealth Technology Develops solutions for treating congestive heart failure | Health Technology |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Kuros Biosciences Ltd.
 Kuros Biosciences Ltd. BiotechnologyHealth Technology Develops biological products for tissue repair | Health Technology |
Inositec AG
Inositec AG Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops treatments for progressive vascular calcification and soft tissue disorders | Health Technology |
Araris Biotech AG
Araris Biotech AG BiotechnologyHealth Technology Operates as a biotechnology company that develops antibody-drug conjugates | Health Technology |
Choisissez Zonebourse 
